CVS Plans Split of Drugstore Unit, Reversing Aetna Merger Strategy
CVS Health announced a plan to separate its drugstore business, unwinding the $78B Aetna deal. Shares dropped 10% on the news.
CVS Health is moving to separate its retail drugstore operations from the rest of its healthcare business, a dramatic strategic reversal that would effectively dismantle the vertically integrated conglomerate the company built through its $78 billion acquisition of health insurer Aetna in 2018, the company announced.
Shares of CVS fell roughly 10% following the disclosure, reflecting investor uncertainty over the complexity and cost of breaking apart a healthcare empire that took years to assemble. The selloff signals that markets are weighing the execution risks of unwinding one of the largest deals in U.S. healthcare history.
Read more Kraft Heinz Sells North American Coffee Unit for $650 Million →
The planned separation would undo the core logic behind the Aetna merger, which was premised on combining pharmacy retail, pharmacy benefit management, and health insurance under a single corporate umbrella to control costs and improve care coordination. The company had argued the integrated model would give it a competitive edge in a rapidly consolidating healthcare sector.
The breakup reflects broader pressures facing large healthcare conglomerates, which have struggled to translate vertical integration into consistent profitability amid rising medical costs, competitive headwinds in pharmacy retail, and regulatory scrutiny. CVS is not alone in reassessing sprawling healthcare combinations built during the deal frenzy of the late 2010s.
Continue reading at Business News
